Oesophageal Cancer

Oncology
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Cook Medical
Cook MedicalIN - Bloomington
1 program
1
radio opaque markersPhase 21 trial
Active Trials
NCT02526134CompletedEst. Jan 2017
Alliance Pharmaceuticals
1 program
Breath testN/A1 trial
Active Trials
NCT04001478Unknown1,000Est. Oct 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Cook Medicalradio opaque markers
Alliance PharmaceuticalsBreath test

Clinical Trials (2)

Total enrollment: 1,000 patients across 2 trials

NCT02526134Cook Medicalradio opaque markers

Placing Trust in Endoscopic Ultrasonography: Impact on Planning Conformal Radiotherapy of Cancer of the Esophagus and Rectum

Start: Apr 2014Est. completion: Jan 2017
Phase 2Completed

Non-invasive Testing for Early oEesophageal Cancer and Dysplasia

Start: Oct 2019Est. completion: Oct 20241,000 patients
N/AUnknown

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space